Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Total Liabilities (Quarterly) : 1.345B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.345B |
| March 31, 2026 | 1.371B |
| December 31, 2025 | 1.526B |
| September 30, 2025 | 1.415B |
| June 30, 2025 | 1.230B |
| March 31, 2025 | 1.704B |
| December 31, 2024 | 1.740B |
| September 30, 2024 | 1.570B |
| June 30, 2024 | 1.771B |
| March 31, 2024 | 1.624B |
| December 31, 2023 | 1.662B |
| September 30, 2023 | 1.614B |
| June 30, 2023 | 1.595B |
| March 31, 2023 | 1.562B |
| December 31, 2022 | 1.568B |
| September 30, 2022 | 1.025B |
| June 30, 2022 | 1.009B |
| March 31, 2022 | 1.033B |
| December 31, 2021 | 833.04M |
| September 30, 2021 | 806.93M |
| June 30, 2021 | 698.73M |
| March 31, 2021 | 490.76M |
| December 31, 2020 | 520.27M |
| September 30, 2020 | 483.65M |
| June 30, 2020 | 480.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 469.82M |
| December 31, 2019 | 480.62M |
| September 30, 2019 | 459.08M |
| June 30, 2019 | 446.21M |
| March 31, 2019 | 451.78M |
| December 31, 2018 | 396.29M |
| September 30, 2018 | 370.11M |
| June 30, 2018 | 353.60M |
| March 31, 2018 | 338.30M |
| December 31, 2017 | 100.99M |
| September 30, 2017 | 84.90M |
| June 30, 2017 | 82.20M |
| March 31, 2017 | 78.98M |
| December 31, 2016 | 83.47M |
| September 30, 2016 | 58.82M |
| June 30, 2016 | 49.12M |
| March 31, 2016 | 45.24M |
| December 31, 2015 | 44.86M |
| September 30, 2015 | 46.74M |
| June 30, 2015 | 43.17M |
| March 31, 2015 | 41.29M |
| December 31, 2014 | 44.63M |
| September 30, 2014 | 36.18M |
| June 30, 2014 | 38.56M |
| March 31, 2014 | 34.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| United Therapeutics Corp. | 819.80M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Biogen, Inc. | 13.24B |
| Gilead Sciences, Inc. | 37.62B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.103B |
| Shareholders Equity (Quarterly) | 757.49M |
| Debt to Equity Ratio | 0.9865 |
| Current Ratio | 3.724 |
| Net Debt Paydown Yield | 0.48% |